Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of MHAA4549A as Monotherapy for Acute Uncomplicated Seasonal Influenza A in Otherwise Healthy Adults

ClinicalTrials.gov ID: NCT02623322

Public ClinicalTrials.gov record NCT02623322. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 1:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of MHAA4549A, a Monoclonal Antibody, Administered as Monotherapy for the Treatment of Acute Uncomplicated Seasonal Influenza A Infection in Otherwise Healthy Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2, randomized, double-blind, placebo-controlled single dose study in otherwise healthy adults with acute uncomplicated seasonal influenza A to assess the safety and tolerability, efficacy, and pharmacokinetics of MHAA4549A.

Study identification

NCT ID
NCT02623322
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
124 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 11, 2016
Primary completion
Nov 12, 2017
Completion
Nov 12, 2017
Last update posted
Jan 7, 2019

2016 – 2017

United States locations

U.S. sites
38
U.S. states
19
U.S. cities
35
Facility City State ZIP Site status
North Alabama Research Center LLC Athens Alabama 35611
WCCT Global, LLC Costa Mesa California 92626
Lalla-Reddy Medical Corporation Fountain Valley California 92708
IMMUNOe Research Centers Centennial Colorado 80112
Integrity Clinical Research Doral Florida 33166
Riverside Clinical Research Edgewater Florida 32132
Sarkis Clinical Trials Gainesville Florida 32607
The Community Research Of South Florida Hialeah Florida 33016
Innovative Clinical Research, Inc. Lauderhill Florida 33319
South Florida Research Center, Inc. Miami Florida 33135
Oceane7 Clinical Research Miami Florida 33144
Central Florida Internists Saint Cloud Florida 34769
Tampa General Hospital Tampa Florida 33606
Advanced Research Institute, Inc. Trinity Florida 34655
Cotton O'Neil Clinical Research Center Topeka Kansas 66606
Professional Research Network of Kansas Wichita Kansas 67205
Heartland Research Associates Wichita Kansas 67207
Kentucky Lung Clinic Hazard Kentucky 41701
MedPharmics Metairie Louisiana 70006
Acadiana Medicine Clinic Opelousas Louisiana 70570
Anne Arundel Medical Center; Anne Arundel Health System Annapolis Maryland 21401
UMASS Memorial Medical Center Worcester Massachusetts 01655
Detroit Medical Center Detroit Michigan 48201
Sinai Grace Hospital Detroit Michigan 48235
William Beaumont Hospital Royal Oak Michigan 48073
Barnes Jewish Hospital St Louis Missouri 63108
Mercury Street Medical Group Butte Montana 59701
Barrett Clinic, P.C. La Vista Nebraska 68128
Global Medical Institutes, LLC Princeton New Jersey 08540
Wake Research Associates Raleigh North Carolina 27612
Center For Medical Research LLC Providence Rhode Island 02908
Emergency MD Boiling Springs South Carolina 29316
HCCA Clinical Research Solutions Franklin Tennessee 37067
Clinical Research Solutions PC Knoxville Tennessee 37920
Clinical Research Solutions, LLC Smyrna Tennessee 37167
University of Texas Medical Branch at Galveston Galveston Texas 77555
Centex Studies Houston Texas 77058
Centex Studies Pharr Texas

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02623322, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 7, 2019 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02623322 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →